Skip to content Skip to navigation

Christopher Paige

Vice President, Research
University Health Network, Canada

Dr. Paige earned a Ph.D. in Immunology at the Sloan-Kettering Division of Cornell University Graduate School of Medical Sciences in 1979. 

Dr. Paige became a Member of the Basel Institute for Immunology in Switzerland where he worked from 1980-1987 before joining the Ontario Cancer Institute as a Senior Scientist in 1987.  In 1990, Dr. Paige became the founding Director of the Arthritis and Autoimmunity Research Centre as well as Director of Research at The Wellesley Hospital.  In 1998, Dr. Paige returned to the Ontario Cancer Institute to assume the role of Vice-President, Research and, subsequently, he assumed his current position of Vice-President, Research at the University Health Network which is comprised of the Toronto General, Toronto Western and Princess Margaret Hospitals.  

Dr. Paige is a Professor in the Departments of Medical Biophysics and Immunology at the University of Toronto. His continuing research interest is in the development of the immune system and in training the immune system to recognize cancer cells. He has served on the Research Advisory Boards of both the National Cancer Institute and the Arthritis Society of Canada.   He was Chairman of BioDiscovery Toronto, a consortium of 12 Toronto based hospitals and universities engaged in the commercialization of research discoveries.  He also serves on the Boards of the Terry Fox Research Institute, Ontario Institute for Cancer Research, Princess Margaret Hospital Foundation, Toronto General and Western Hospital Foundation, Arthritis and Autoimmunity Research Centre Foundation, Council of Ontario Research Directors, and the Ontario Health Research Alliance.  Dr. Paige is also a co-founder and Chairman of the Board of GEMMA Biotechnology.  Its purpose is to discover and commercially develop biological response modifiers that influence the course of human disease. Dr. Paige is the Founder and co-Director of the Shanghai-Toronto Institute for Health Science, a partnership between the Shanghai Institute of Health Sciences, Shanghai Institute of Organic Chemistry, and the University Health Network. STI was founded to promote collaboration between medical researchers in Shanghai and Toronto and has laboratories in the Zhangjiang High Technology Park in Pudong.

Return to Board of Directors